American Century Companies Inc. Sells 25,845 Shares of DaVita Inc. (NYSE:DVA)

American Century Companies Inc. cut its stake in shares of DaVita Inc. (NYSE:DVA) by 29.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 62,803 shares of the company’s stock after selling 25,845 shares during the period. American Century Companies Inc. owned 0.08% of DaVita worth $9,392,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. SBI Securities Co. Ltd. bought a new stake in DaVita during the 4th quarter worth approximately $41,000. Quarry LP purchased a new position in shares of DaVita during the 3rd quarter valued at $60,000. Venturi Wealth Management LLC increased its holdings in shares of DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after purchasing an additional 152 shares during the period. Versant Capital Management Inc raised its position in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after buying an additional 169 shares in the last quarter. Finally, Blue Trust Inc. boosted its stake in DaVita by 39.7% during the fourth quarter. Blue Trust Inc. now owns 461 shares of the company’s stock valued at $76,000 after buying an additional 131 shares during the period. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Stock Up 1.6 %

Shares of DVA opened at $154.37 on Thursday. DaVita Inc. has a 1 year low of $125.64 and a 1 year high of $179.60. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The stock has a 50 day simple moving average of $156.49 and a two-hundred day simple moving average of $157.41. The firm has a market cap of $12.35 billion, a P/E ratio of 14.37, a P/E/G ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. On average, analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on DVA. StockNews.com lowered DaVita from a “buy” rating to a “hold” rating in a research note on Wednesday. Cowen reaffirmed a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Barclays boosted their price target on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price objective on shares of DaVita in a research report on Friday, February 21st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.